Actos (Pioglitazone) Cost in North Carolina 2026: Prices, Insurance, and Savings

What Does Pioglitazone Actually Cost at North Carolina Pharmacies?

The average cash price for generic pioglitazone across North Carolina retail pharmacies sits at roughly $15 per month in 2026, making it one of the least expensive branded-to-generic diabetes medications on the market. Takeda's branded Actos and its authorized generics carry a list price of about $60 per month, but almost no one pays that figure out of pocket.

Pricing varies by pharmacy chain, county, and whether you present a discount card. A 30-day supply of pioglitazone 15 mg or 30 mg tablets at large chains like CVS, Walgreens, or Walmart in Charlotte, Raleigh, or Greensboro typically falls between $10 and $22 without insurance. Independent pharmacies in rural counties may quote slightly higher or lower depending on their wholesaler agreements.

The generic became available after Actos lost patent exclusivity in 2012. Multiple manufacturers now produce pioglitazone tablets, which has driven prices steadily downward. According to the FDA's Orange Book, more than a dozen approved generic formulations exist. That level of competition keeps the drug affordable relative to newer diabetes agents like SGLT2 inhibitors or GLP-1 receptor agonists, which can exceed $900 per month at list price.

For patients filling at military pharmacies (Fort Liberty, formerly Fort Bragg) or VA facilities in North Carolina, pioglitazone is typically available at zero copay through TRICARE or Veterans Health Administration formularies. The Department of Veterans Affairs National Formulary has included thiazolidinediones for years.

Does North Carolina Medicaid Cover Pioglitazone?

NC Medicaid covers generic pioglitazone for its FDA-approved indication of type 2 diabetes mellitus, but the program does not cover it for off-label uses such as nonalcoholic steatohepatitis (NASH). Patients seeking coverage for NASH or metabolic-associated steatotic liver disease (MASLD) will need to appeal or pay out of pocket.

North Carolina transitioned to Medicaid managed care under the NC Medicaid Managed Care program (formerly Medicaid Transformation). Under this system, five prepaid health plans (PHPs) administer pharmacy benefits. Each PHP maintains its own preferred drug list (PDL), but generic pioglitazone appears on all five for type 2 diabetes. Copays for Medicaid recipients in NC are capped at $3 for generic medications per federal rules.

The off-label coverage gap matters because pioglitazone is the only oral medication with strong randomized trial evidence for NASH. The PIVENS trial (N=247) published in the New England Journal of Medicine demonstrated that pioglitazone 30 mg daily significantly improved hepatic steatosis and lobular inflammation compared with placebo over 96 weeks. Dr. Arun Sanyal, the lead investigator, noted that "pioglitazone was associated with reductions in hepatic steatosis and lobular inflammation" in patients without diabetes. Despite this evidence, Medicaid programs in most states, North Carolina included, restrict coverage to labeled indications unless a prior authorization is approved.

Patients who need pioglitazone for NASH can file a prior authorization request through their PHP. Success rates vary, but attaching the PIVENS data and a hepatologist's letter strengthens the case. At $15 per month cash, some patients simply bypass the appeals process and pay directly.

Insurance Coverage Beyond Medicaid

Most commercial insurance plans available through the North Carolina ACA marketplace or employer-sponsored coverage place generic pioglitazone on Tier 1 (preferred generic), with copays between $0 and $15 per month. Blue Cross Blue Shield of North Carolina, the state's largest insurer with roughly 3.9 million covered lives, lists pioglitazone on its lowest generic tier.

UnitedHealthcare, Aetna, Cigna, and Ambetter plans sold in NC follow a similar pattern. Brand-name Actos, if specifically requested, lands on Tier 3 (non-preferred brand) with copays of $40 to $75. There is almost never a clinical reason to request brand Actos over the generic, as the FDA considers the formulations therapeutically equivalent (rated AB).

Medicare Part D plans in North Carolina also cover pioglitazone generics. Under the Inflation Reduction Act provisions that took effect in 2025, out-of-pocket prescription costs for Medicare beneficiaries are capped at $2,000 annually. For a drug costing $15 per month, this cap is unlikely to matter, but it provides an additional safety net for patients on multiple medications.

A 2023 analysis in Diabetes Care from the American Diabetes Association's Standards of Care confirmed that thiazolidinediones remain a cost-effective second-line option after metformin, precisely because of their low generic price. The ADA's cost table listed pioglitazone at the lowest tier for monthly expense among all oral diabetes drugs.

Is Compounded Pioglitazone Legal in North Carolina?

Compounded pioglitazone is legal in North Carolina when prepared by a licensed 503A compounding pharmacy operating under a valid patient-specific prescription. Federal law under the Drug Quality and Security Act (2013) distinguishes between 503A pharmacies (patient-specific) and 503B outsourcing facilities (batch production).

North Carolina's Board of Pharmacy regulates 503A compounding pharmacies under NCGS §90-85.3A. These pharmacies can compound pioglitazone into alternative dosage forms (suspensions for patients who cannot swallow tablets, customized low-dose capsules) when a prescriber documents a clinical need that commercially available products do not meet.

Compounded pioglitazone pricing in NC varies. Some 503A pharmacies advertise compounded oral capsules at comparable or even lower prices than the generic tablet, particularly for non-standard doses like 7.5 mg, which are not commercially manufactured. Patients using telehealth platforms that partner with compounding pharmacies may see bundled pricing that includes the consultation fee and medication.

One caution: compounded medications do not undergo the same FDA bioequivalence testing as approved generics. The FDA's guidance on compounding emphasizes that compounded drugs should be used only when an FDA-approved product cannot meet the patient's needs. For most patients, the commercially available 15 mg, 30 mg, or 45 mg tablets are appropriate.

Telehealth Access to Pioglitazone in North Carolina

North Carolina permits telehealth prescribing of pioglitazone under the state's telehealth parity laws. A clinician licensed in NC can evaluate a patient via synchronous video or audio visit and prescribe pioglitazone without an in-person exam, provided they establish an adequate provider-patient relationship.

The NC Medical Board updated its telehealth position statement in 2024, aligning with the Interstate Medical Licensure Compact framework. Prescribers holding compact licenses can treat NC residents remotely. This expands access for patients in rural western NC counties (such as Cherokee, Graham, and Swain) where endocrinology offices are scarce.

Telehealth platforms operating in NC typically charge $30 to $75 for an initial diabetes consultation. Combined with the $15 monthly medication cost, the total first-month expense for a new pioglitazone prescription via telehealth runs $45 to $90. Subsequent refills require only the pharmacy cost if the prescriber writes a 90-day prescription with refills.

A 2021 study in the Annals of Internal Medicine found that telehealth diabetes management produced HbA1c reductions comparable to in-person care (weighted mean difference 0.077%, 95% CI -0.13 to 0.29), supporting telehealth as a viable prescribing pathway for medications like pioglitazone.

Discount Programs and Savings Cards Available in North Carolina

Several programs reduce pioglitazone costs for NC residents who are uninsured or underinsured. The most direct route is a pharmacy discount card from platforms like GoodRx, RxSaver, or SingleCare, which can bring the price below $10 at select pharmacies.

Takeda, the manufacturer of brand Actos, previously offered a savings card program, though its utility has diminished since generic entry. Some generic manufacturers offer copay assistance through programs indexed on NeedyMeds and RxAssist databases. Eligibility typically requires household income below 200% to 400% of the federal poverty level.

North Carolina-specific resources include:

NC MedAssist operates a free pharmacy program for uninsured NC residents earning below 200% FPL. Pioglitazone is available through their formulary at no cost to qualifying patients. The program served over 26,000 patients in 2024.

340B pharmacies in NC (including those at Federally Qualified Health Centers like Piedmont Health and Blue Ridge Health) can dispense pioglitazone at significantly reduced prices. The 340B Drug Pricing Program requires manufacturers to provide outpatient drugs to eligible healthcare organizations at a discount of 25% to 50% off the average manufacturer price.

Walmart $4 generics list includes pioglitazone at many NC locations. A 30-day supply for $4 or a 90-day supply for $10 makes this one of the cheapest options available, though availability should be confirmed at the specific Walmart pharmacy.

Clinical Context: When Pioglitazone Is Prescribed

Pioglitazone is an oral thiazolidinedione (TZD) that improves insulin sensitivity in muscle, adipose tissue, and liver. The FDA approved it in 1999 as an adjunct to diet and exercise for type 2 diabetes mellitus.

Beyond glycemic control, pioglitazone has demonstrated cardiovascular and hepatic benefits that keep it clinically relevant despite being a 27-year-old medication. The PROactive trial (N=5,238) showed a 16% reduction in the composite secondary endpoint of all-cause mortality, non-fatal myocardial infarction, and stroke (HR 0.84 to 95% CI 0.72-0.98, p=0.027) in patients with type 2 diabetes and macrovascular disease.

For NASH/MASLD, pioglitazone remains the only oral drug with Phase III evidence. The PIVENS trial demonstrated resolution of steatohepatitis in 47% of pioglitazone-treated patients versus 21% on placebo (p=0.001) [1]. The AASLD Practice Guidance (2023) recommends pioglitazone for pharmacotherapy of biopsy-confirmed NASH, regardless of diabetes status.

Common side effects include weight gain (mean 2.5 to 4.7 kg over 12 months), peripheral edema, and an increased fracture risk in postmenopausal women. The drug carries a black-box warning for congestive heart failure exacerbation. Standard starting dose is 15 mg or 30 mg once daily, with a maximum of 45 mg daily.

How North Carolina Compares to Neighboring States

Pioglitazone pricing in NC is broadly consistent with other southeastern states. Cash prices in South Carolina, Virginia, Tennessee, and Georgia cluster in the $12 to $20 range for a 30-day generic supply.

The meaningful differences lie in Medicaid policies. Virginia Medicaid covers pioglitazone for both diabetes and NASH through a prior authorization pathway that explicitly references the AASLD guidance. South Carolina Medicaid, like North Carolina, restricts coverage to the diabetes indication. Tennessee's TennCare program covers generic pioglitazone without prior authorization for diabetes.

For NC residents near the Virginia border (cities like Henderson, Danville corridor), filling prescriptions at VA pharmacies is not advantageous since prices are similar. The decision point is Medicaid coverage for off-label use. NC patients seeking NASH coverage may find Virginia's PA pathway more accommodating if they have dual-state options through employment or spousal coverage.

According to CMS data on state Medicaid drug utilization, North Carolina ranked 11th nationally in total pioglitazone prescriptions filled through Medicaid in 2024, reflecting the state's large Medicaid-eligible population of approximately 2.9 million.